Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

US Pet Supplies Market

ID: MRFR/CG/14070-HCR
100 Pages
Garvit Vyas
Last Updated: April 06, 2026

US Pet Supplies Market Size, Share, Industry Trend & Analysis Research Report By Type Outlook ( Food, Grooming Products, Toys, Health Supplements, Accessories ), Animal Type Outlook ( Dogs, Cats, Birds, Fish, Small Mammals ), Sales Channel Outlook ( Online Retail, Brick-and-Mortar Stores, Pet Specialty Stores, Wholesale, Veterinary Clinics ), and Customer Segment Outlook ( Pet Owners, Pet Professionals, Pet Retailers, Commercial Pet Services ) forecast by 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

US Pet Supplies Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Pharmaceutical, BY Type (USD Billion)
  49.     4.1.1 Food
  50.     4.1.2 Grooming Products
  51.     4.1.3 Toys
  52.     4.1.4 Health Supplements
  53.     4.1.5 Accessories
  54.   4.2 Pharmaceutical, BY Animal Type (USD Billion)
  55.     4.2.1 Dogs
  56.     4.2.2 Cats
  57.     4.2.3 Birds
  58.     4.2.4 Fish
  59.     4.2.5 Small Mammals
  60.   4.3 Pharmaceutical, BY Sales Channel (USD Billion)
  61.     4.3.1 Online Retail
  62.     4.3.2 Brick-and-Mortar Stores
  63.     4.3.3 Pet Specialty Stores
  64.     4.3.4 Wholesale
  65.     4.3.5 Veterinary Clinics
  66.   4.4 Pharmaceutical, BY Customer Segment (USD Billion)
  67.     4.4.1 Pet Owners
  68.     4.4.2 Pet Professionals
  69.     4.4.3 Pet Retailers
  70.     4.4.4 Commercial Pet Services
  71. 5 SECTION V: COMPETITIVE ANALYSIS
  72.   5.1 Competitive Landscape
  73.     5.1.1 Overview
  74.     5.1.2 Competitive Analysis
  75.     5.1.3 Market share Analysis
  76.     5.1.4 Major Growth Strategy in the Pharmaceutical
  77.     5.1.5 Competitive Benchmarking
  78.     5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
  79.     5.1.7 Key developments and growth strategies
  80.       5.1.7.1 New Product Launch/Service Deployment
  81.       5.1.7.2 Merger & Acquisitions
  82.       5.1.7.3 Joint Ventures
  83.     5.1.8 Major Players Financial Matrix
  84.       5.1.8.1 Sales and Operating Income
  85.       5.1.8.2 Major Players R&D Expenditure. 2023
  86.   5.2 Company Profiles
  87.     5.2.1 PetSmart (US)
  88.       5.2.1.1 Financial Overview
  89.       5.2.1.2 Products Offered
  90.       5.2.1.3 Key Developments
  91.       5.2.1.4 SWOT Analysis
  92.       5.2.1.5 Key Strategies
  93.     5.2.2 Chewy (US)
  94.       5.2.2.1 Financial Overview
  95.       5.2.2.2 Products Offered
  96.       5.2.2.3 Key Developments
  97.       5.2.2.4 SWOT Analysis
  98.       5.2.2.5 Key Strategies
  99.     5.2.3 Nestle Purina PetCare (US)
  100.       5.2.3.1 Financial Overview
  101.       5.2.3.2 Products Offered
  102.       5.2.3.3 Key Developments
  103.       5.2.3.4 SWOT Analysis
  104.       5.2.3.5 Key Strategies
  105.     5.2.4 Mars Petcare (US)
  106.       5.2.4.1 Financial Overview
  107.       5.2.4.2 Products Offered
  108.       5.2.4.3 Key Developments
  109.       5.2.4.4 SWOT Analysis
  110.       5.2.4.5 Key Strategies
  111.     5.2.5 Spectrum Brands (US)
  112.       5.2.5.1 Financial Overview
  113.       5.2.5.2 Products Offered
  114.       5.2.5.3 Key Developments
  115.       5.2.5.4 SWOT Analysis
  116.       5.2.5.5 Key Strategies
  117.     5.2.6 Hill's Pet Nutrition (US)
  118.       5.2.6.1 Financial Overview
  119.       5.2.6.2 Products Offered
  120.       5.2.6.3 Key Developments
  121.       5.2.6.4 SWOT Analysis
  122.       5.2.6.5 Key Strategies
  123.     5.2.7 Petco (US)
  124.       5.2.7.1 Financial Overview
  125.       5.2.7.2 Products Offered
  126.       5.2.7.3 Key Developments
  127.       5.2.7.4 SWOT Analysis
  128.       5.2.7.5 Key Strategies
  129.     5.2.8 Central Garden & Pet (US)
  130.       5.2.8.1 Financial Overview
  131.       5.2.8.2 Products Offered
  132.       5.2.8.3 Key Developments
  133.       5.2.8.4 SWOT Analysis
  134.       5.2.8.5 Key Strategies
  135.   5.3 Appendix
  136.     5.3.1 References
  137.     5.3.2 Related Reports
  138. 6 LIST OF FIGURES
  139.   6.1 MARKET SYNOPSIS
  140.   6.2 US MARKET ANALYSIS BY TYPE
  141.   6.3 US MARKET ANALYSIS BY ANIMAL TYPE
  142.   6.4 US MARKET ANALYSIS BY SALES CHANNEL
  143.   6.5 US MARKET ANALYSIS BY CUSTOMER SEGMENT
  144.   6.6 KEY BUYING CRITERIA OF PHARMACEUTICAL
  145.   6.7 RESEARCH PROCESS OF MRFR
  146.   6.8 DRO ANALYSIS OF PHARMACEUTICAL
  147.   6.9 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
  148.   6.10 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
  149.   6.11 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
  150.   6.12 PHARMACEUTICAL, BY TYPE, 2024 (% SHARE)
  151.   6.13 PHARMACEUTICAL, BY TYPE, 2024 TO 2035 (USD Billion)
  152.   6.14 PHARMACEUTICAL, BY ANIMAL TYPE, 2024 (% SHARE)
  153.   6.15 PHARMACEUTICAL, BY ANIMAL TYPE, 2024 TO 2035 (USD Billion)
  154.   6.16 PHARMACEUTICAL, BY SALES CHANNEL, 2024 (% SHARE)
  155.   6.17 PHARMACEUTICAL, BY SALES CHANNEL, 2024 TO 2035 (USD Billion)
  156.   6.18 PHARMACEUTICAL, BY CUSTOMER SEGMENT, 2024 (% SHARE)
  157.   6.19 PHARMACEUTICAL, BY CUSTOMER SEGMENT, 2024 TO 2035 (USD Billion)
  158.   6.20 BENCHMARKING OF MAJOR COMPETITORS
  159. 7 LIST OF TABLES
  160.   7.1 LIST OF ASSUMPTIONS
  161.     7.1.1
  162.   7.2 US MARKET SIZE ESTIMATES; FORECAST
  163.     7.2.1 BY TYPE, 2025-2035 (USD Billion)
  164.     7.2.2 BY ANIMAL TYPE, 2025-2035 (USD Billion)
  165.     7.2.3 BY SALES CHANNEL, 2025-2035 (USD Billion)
  166.     7.2.4 BY CUSTOMER SEGMENT, 2025-2035 (USD Billion)
  167.   7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  168.     7.3.1
  169.   7.4 ACQUISITION/PARTNERSHIP
  170.     7.4.1

US Pharmaceutical Market Segmentation

Pharmaceutical By Type (USD Billion, 2025-2035)

  • Food
  • Grooming Products
  • Toys
  • Health Supplements
  • Accessories

Pharmaceutical By Animal Type (USD Billion, 2025-2035)

  • Dogs
  • Cats
  • Birds
  • Fish
  • Small Mammals

Pharmaceutical By Sales Channel (USD Billion, 2025-2035)

  • Online Retail
  • Brick-and-Mortar Stores
  • Pet Specialty Stores
  • Wholesale
  • Veterinary Clinics

Pharmaceutical By Customer Segment (USD Billion, 2025-2035)

  • Pet Owners
  • Pet Professionals
  • Pet Retailers
  • Commercial Pet Services

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions